{
  "url": "https://openlegislation.uk/eu-regulation-2004-1646/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-2004-1646/annex.json",
  "legislation": "eur/2004/1646",
  "legislation_title": "Commission Regulation (EC) No 1646/2004 of 20 September 2004 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2004-1646",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "The following substance(s) is(are) inserted in Annex I:\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\n‘Albendazole\nSum of albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole\nAll ruminants\n100 μg/kg\nMuscle\n100 μg/kg\nFat\n1 000 μg/kg\nLiver\n500 μg/kg\nKidney\n100 μg/kg\nMilk\nFebantel\nSum of extractable residues which may be oxidised to oxfendazole sulphone\nAll ruminants\n50 μg/kg\nMuscle\n50 μg/kg\nFat\n500 μg/kg\nLiver\n50 μg/kg\nKidney\n10 μg/kg\nMilk\nFenbendazole\nSum of extractable residues which may be oxidised to oxfendazole sulphone\nAll ruminants\n50 μg/kg\nMuscle\n50 μg/kg\nFat\n500 μg/kg\nLiver\n50 μg/kg\nKidney\n10 μg/kg\nMilk\nOxfendazole\nSum of extractable residues which may be oxidised to oxfendazole sulphone\nAll ruminants\n50 μg/kg\nMuscle\n50 μg/kg\nFat\n500 μg/kg\nLiver\n50 μg/kg\nKidney\n10 μg/kg\nMilk\nThiabendazole\nSum of thiabendazole and 5-hydroxythiabendazole\nCaprine\n100 μg/kg\nMuscle\n100 μg/kg\nFat\n100 μg/kg\nLiver\n100 μg/kg\nKidney\n100 μg/kg\nMilk’\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\n‘Oxyclozanide\nOxyclozanide\nAll ruminants\n20 μg/kg\nMuscle\n20 μg/kg\nFat\n500 μg/kg\nLiver\n100 μg/kg\nKidney\n10 μg/kg\nMilk’\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\n‘Amitraz\nSum of amitraz and all metabolites containing the 2,4-dimethylaniline moiety, expressed as amitraz\nCaprine\n200 μg/kg\nFat\n100 μg/kg\nLiver\n200 μg/kg\nKidney\n10 μg/kg\nMilk’\nFurther provisions in Commission Directive 98/82/EC are to be observed (OJ L290, 29.10.1998, p. 25).’\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\n‘Cypermethrin\nCypermethrin (sum of isomers)\nAll ruminants\n20 μg/kg\nMuscle\n200 μg/kg\nFat\n20 μg/kg\nLiver\n20 μg/kg\nKidney\n20 μg/kg\nMilk\nDeltamethrin\nDeltamethrin\nAll ruminants\n10 μg/kg\nMuscle\n50 μg/kg\nFat\n10 μg/kg\nLiver\n10 μg/kg\nKidney\n20 μg/kg\nMilk\nPharmacologically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\n‘Dexamethasone\nDexamethasone\nCaprine\n0,75 μg/kg\nMuscle\n2 μg/kg\nLiver\n0,75 μg/kg\nKidney\n0,3 μg/kg\nMilk’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Further provisions in Commission Directive 98/82/EC are to be observed (OJ L290, 29.10.1998, p. 25).’"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2004/1646/annex",
    "retrieved_at": "2026-11-01T14:55:16.646149+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}